Earnings call transcript: HSBC Q1 2026 earnings fall short, stock rises

HSBC reported a sharp Q1 EPS miss at $0.44 versus $2.14 expected, but revenue slightly beat at $18.62B and pre-market shares rose 1.41% to $91.40. The bank raised full-year banking NII guidance to about $46B and kept its quarterly dividend at $0.10, while flagging a 52bp Q1 ECL charge and fraud-related/private credit risks. Management reiterated 2028 targets for 5% annual revenue growth and 17%+ RoTE, with wealth and Hong Kong momentum offsetting earnings pressure.

Analysis

The market is likely keying off the quality of the beat, not the headline miss: HSBC is showing that earnings volatility can coexist with improving franchise momentum when the balance sheet is being actively simplified. The second-order implication is that capital can be redeployed faster than the market model assumes, which matters because the bank is simultaneously generating excess capital, narrowing the operating business mix, and lifting medium-term fee visibility through wealth. That combination should support a higher multiple relative to slower-growing global peers if management keeps buybacks optionality alive into Q2.

The main hidden risk is that the quarter is masking a less benign credit path. The new guidance embeds a meaningfully wider loss assumption, but the more important issue is regime change: once management starts describing specific, idiosyncratic sponsor-related losses and geopolitically linked reserves in the same breath, investors will demand a higher risk premium on private-credit-adjacent exposures across the European banking complex. That is a subtle negative for names with similar “low-risk” narratives in structured lending, even if they are not directly exposed to the same credits.

Near term, the stock can stay supported because the revenue and capital story is good enough to offset the EPS noise, and because the bank is signaling confidence with a steady dividend and potential buyback restart after Q2. Over 3-6 months, the key catalyst is whether the upgraded NII outlook proves conservative as rates and deposit mix stabilize; if so, the rerating can extend. The contrarian take is that the quarter may actually understate the durability of wealth earnings, since a growing asset base is still feeding through with a lag, so consensus may be too focused on current P&L conversion and not enough on the embedded earnings run-rate.

Key Decisions for Investors

• Long HSBC vs. short BCS on a 3-6 month horizon: HSBC has cleaner capital and a clearer wealth/Asia monetization path, while Barclays has less direct offset from fee and balance-sheet mix. Target is relative multiple expansion if HSBC confirms buyback restart in Q2; stop if credit commentary worsens across both names.
• Buy HSBC shares on pullbacks below the pre-market spike, with a 1-2 month hold into Q2 capital-return updates. Risk/reward favors owning the high-quality cash flow franchise before buybacks are reactivated; trim if the stock rerates ahead of formal repurchase guidance.
• Pair long HSBC / short C for a 6-month trade: HSBC’s Asia wealth and deposit franchise should be more insulated than a more rate-sensitive U.S. banking name if global growth softens. This works best if U.K./Asia rates stay stable and risk costs normalize.
• Use HSBC call spreads expiring after the Q2 print to express upside from buyback and NII confirmation while capping premium at risk. Favor strikes around 5-10% above spot to monetize a gradual rerating rather than a sharp squeeze.
• Avoid levering into GS/JPM as a read-through on private credit risks; instead watch for sympathy weakness in any bank with sponsor-financed securitization exposure. If that basket underperforms over the next 1-3 weeks, it may be a better short than HSBC itself.